< Back to previous page

Publication

Authors' reply to comment on "Cost-effectiveness analysis of Herpes Zoster vaccination in 50-to 85-year-old immunocompetent Belgian cohorts: a comparison between no vaccination, the adjuvanted subunit vaccine, and live-attenuated vaccine"

Journal Contribution - Letter to Editor

Journal: Pharmacoeconomics

ISSN: 1170-7690

Volume: 40

Pages: 1013 - 1014

Publication year:2022

Keywords:L1 Letter to the editor

WoS Id: 000859912900002
DOI: https://doi.org/10.1007/s40273-022-01186-y
Handle: https://hdl.handle.net/10067/1914710151162165141

Accessibility:Open